Indianapolis, IN (October 31, 2008) - The Indiana Health Industry Forum announced today that registration is open for a
conference highlighting, “Emerging Trends and New Developments in Cancer Discovery, Diagnosis and Treatment”.
The conference will be held December 1-2, 2008 at University Place Conference Center in Indianapolis.
The conference is presented by the Indiana Health Industry Forum with headline sponsorship by the Indiana University
Melvin and Bren Simon Cancer Center. Dr. Mark R. Kelley with the IU Simon Cancer Center serves as the conference
chairman. “This conference is intended to highlight Indiana-based achievements in cancer research, diagnostics and
treatment.” says Kelley. “We hope this event will facilitate opportunities for networking, collaboration and partnering
among researchers, companies, and care delivery organizations. It should help everyone develop a better understanding
of the cancer care system and, importantly, build and strengthen the climate for translational research in Indiana”.
The conference features a poster display to emphasize the companies, organizations and universities that have
developed unique approaches or support for cancer detection
or treatment. The event will also offer a combination of presentations, panel discussions and networking including two
keynote addresses with remarks from:
• Eric K. Rowinsky, M.D., Chief Medical Officer, Executive Vice President ImClone Systems, Inc., and
• Douglas W. Blayney, M.D., Medical Director, University of Michigan Comprehensive Cancer Center; President-
Elect, American Society of Clinical Oncology
“This is the third event in an on-going series that examines Indiana’s life sciences research strengths”, says Dan
Peterson, IHIF Board Chairman and Vice President of Industry & Government Affairs for Cook Group Inc. “This year’s
Cancer/Oncology Summit brings together a broad range of Indiana institutions, companies and individuals with a common
interest in cancer research, diagnosis and treatment and fosters the collaboration and connections that help drive
Registration is available on-line through the IHIF website at www.ihif.org. Additional support and sponsorship for this
event is provided by Purdue University, Cabello & Associates, Barnes & Thornburg, University of Notre Dame Cancer
Institute, BioCrossroads, Semafore Pharmaceuticals, DC Limited, St. Francis Hospital and ATAIN. The conference is also
supported by an educational grant from Eli Lilly and Co.
The Indiana Health Industry Forum (IHIF) is a not-for-profit, private sector organization with members that represent a
private/public alliance of manufacturers, healthcare providers, suppliers, educational institutions, service providers and
government officials. Its mission is to create an environment where Indiana is a premier location for the creation and
growth of health industry enterprises. To learn more, please visit www.ihif.org or contact IHIF at 317.278-9970.
About IU Simon Cancer Center
The Indiana University Melvin and Bren Simon Cancer Center is an Indiana University School of Medicine and Clarian
Health partnership. Located in Indianapolis, IU Simon Cancer Center serves as a regional and national referral center for
state-of-the-art cancer treatment and is Indiana’s only National Cancer Institute-designated cancer center that provides
patient care. The partnership between IU School of Medicine and Clarian Health is dedicated to establishing a state-wide
health care delivery system that is supported by the scientific resources and clinical expertise of the medical school.
Its mission is to advance the understanding, prevention and treatment of cancer throughout Indiana and the world with
patient-centered care, acceleration of promising science and collaborative educational programs. For more information